John Hampton Arnold, Jr., M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
High-Frequency Ventilation | 23 | 2015 | 87 | 4.470 |
Why?
|
Respiration, Artificial | 32 | 2020 | 2569 | 2.610 |
Why?
|
Positive-Pressure Respiration | 22 | 2020 | 633 | 2.610 |
Why?
|
Pulmonary Gas Exchange | 22 | 2012 | 382 | 2.390 |
Why?
|
Tomography | 12 | 2020 | 390 | 2.210 |
Why?
|
Intensive Care Units, Pediatric | 22 | 2021 | 981 | 2.020 |
Why?
|
Lung Volume Measurements | 12 | 2012 | 378 | 1.620 |
Why?
|
Electric Impedance | 13 | 2020 | 729 | 1.540 |
Why?
|
Fluorocarbons | 11 | 2010 | 452 | 1.490 |
Why?
|
Acute Lung Injury | 5 | 2013 | 380 | 1.390 |
Why?
|
Respiratory Insufficiency | 13 | 2019 | 1199 | 1.360 |
Why?
|
Respiratory Distress Syndrome, Newborn | 8 | 2010 | 214 | 1.140 |
Why?
|
Respiratory Dead Space | 8 | 2019 | 30 | 1.120 |
Why?
|
Carbon Dioxide | 13 | 2012 | 1150 | 1.110 |
Why?
|
Lung | 19 | 2018 | 9856 | 0.870 |
Why?
|
Ventilator Weaning | 8 | 2011 | 148 | 0.820 |
Why?
|
Lung Injury | 6 | 2010 | 436 | 0.800 |
Why?
|
Breath Tests | 8 | 2015 | 280 | 0.730 |
Why?
|
Monitoring, Physiologic | 7 | 2017 | 1738 | 0.710 |
Why?
|
Prone Position | 5 | 2006 | 194 | 0.710 |
Why?
|
Tidal Volume | 10 | 2019 | 490 | 0.690 |
Why?
|
Extracorporeal Membrane Oxygenation | 10 | 2012 | 1354 | 0.690 |
Why?
|
Pulmonary Ventilation | 5 | 2010 | 373 | 0.680 |
Why?
|
Nebulizers and Vaporizers | 2 | 2016 | 139 | 0.590 |
Why?
|
Pulmonary Atelectasis | 3 | 2013 | 145 | 0.590 |
Why?
|
Ventilator-Induced Lung Injury | 3 | 2016 | 122 | 0.560 |
Why?
|
Respiratory Mechanics | 6 | 2011 | 686 | 0.530 |
Why?
|
Diaphragm | 3 | 2011 | 349 | 0.520 |
Why?
|
Lung Compliance | 5 | 2019 | 195 | 0.490 |
Why?
|
Oxygen | 8 | 2019 | 4189 | 0.490 |
Why?
|
Liquid Ventilation | 3 | 2003 | 7 | 0.480 |
Why?
|
Ribavirin | 1 | 2016 | 395 | 0.470 |
Why?
|
Infant | 36 | 2021 | 35136 | 0.470 |
Why?
|
Plethysmography | 2 | 2005 | 180 | 0.450 |
Why?
|
Child, Preschool | 38 | 2021 | 41006 | 0.450 |
Why?
|
Dexmedetomidine | 1 | 2017 | 315 | 0.440 |
Why?
|
Infant, Newborn | 33 | 2021 | 25625 | 0.440 |
Why?
|
Hernia, Diaphragmatic | 4 | 2010 | 250 | 0.430 |
Why?
|
Respiratory Function Tests | 5 | 2012 | 1616 | 0.430 |
Why?
|
Blood Gas Analysis | 5 | 2015 | 383 | 0.420 |
Why?
|
Child | 44 | 2021 | 77709 | 0.400 |
Why?
|
Goals | 1 | 2017 | 706 | 0.390 |
Why?
|
Barotrauma | 2 | 2016 | 37 | 0.380 |
Why?
|
Pulmonary Alveoli | 4 | 2012 | 675 | 0.380 |
Why?
|
Hydrocarbons, Brominated | 6 | 2010 | 28 | 0.370 |
Why?
|
Signal Processing, Computer-Assisted | 2 | 2017 | 1534 | 0.360 |
Why?
|
Hypnotics and Sedatives | 5 | 2017 | 1162 | 0.320 |
Why?
|
Sheep | 10 | 2004 | 1437 | 0.320 |
Why?
|
Intermittent Positive-Pressure Ventilation | 1 | 2008 | 13 | 0.320 |
Why?
|
Disease Models, Animal | 12 | 2013 | 18029 | 0.320 |
Why?
|
Persistent Fetal Circulation Syndrome | 2 | 2004 | 80 | 0.300 |
Why?
|
Anesthesia, Inhalation | 1 | 2008 | 223 | 0.290 |
Why?
|
Pharmacokinetics | 1 | 2007 | 88 | 0.290 |
Why?
|
Cardiac Output | 3 | 2003 | 854 | 0.290 |
Why?
|
Hemodynamics | 11 | 2015 | 4199 | 0.280 |
Why?
|
Swine | 10 | 2013 | 5917 | 0.280 |
Why?
|
Random Allocation | 5 | 2013 | 2429 | 0.280 |
Why?
|
Critical Care | 7 | 2007 | 2647 | 0.280 |
Why?
|
Intensive Care, Neonatal | 1 | 2008 | 198 | 0.270 |
Why?
|
Anesthesia | 1 | 2017 | 1561 | 0.270 |
Why?
|
Respiration | 2 | 2011 | 1653 | 0.270 |
Why?
|
Uteroglobin | 1 | 2005 | 58 | 0.270 |
Why?
|
Nitric Oxide | 5 | 2004 | 2132 | 0.260 |
Why?
|
Supine Position | 3 | 2006 | 205 | 0.260 |
Why?
|
Respiratory Tract Diseases | 1 | 2011 | 722 | 0.260 |
Why?
|
Plethysmography, Impedance | 1 | 2005 | 43 | 0.260 |
Why?
|
Isoflurane | 3 | 2012 | 380 | 0.260 |
Why?
|
Enteral Nutrition | 1 | 2011 | 763 | 0.250 |
Why?
|
Adolescent | 29 | 2021 | 85781 | 0.240 |
Why?
|
Drug Delivery Systems | 1 | 2016 | 2219 | 0.240 |
Why?
|
Ventilators, Mechanical | 5 | 2016 | 292 | 0.240 |
Why?
|
Prospective Studies | 22 | 2020 | 53288 | 0.240 |
Why?
|
Psychomotor Agitation | 1 | 2006 | 293 | 0.230 |
Why?
|
Antiviral Agents | 1 | 2016 | 2987 | 0.230 |
Why?
|
Humans | 90 | 2021 | 744343 | 0.220 |
Why?
|
Pulmonary Surfactants | 2 | 2004 | 162 | 0.220 |
Why?
|
Algorithms | 9 | 2016 | 13881 | 0.210 |
Why?
|
Intracranial Hemorrhages | 2 | 2004 | 855 | 0.200 |
Why?
|
Conscious Sedation | 1 | 2006 | 528 | 0.200 |
Why?
|
Animals | 35 | 2013 | 168757 | 0.190 |
Why?
|
Infant, Premature, Diseases | 2 | 2004 | 706 | 0.190 |
Why?
|
Bronchiolitis | 1 | 2007 | 458 | 0.190 |
Why?
|
Quality Improvement | 1 | 2016 | 3749 | 0.190 |
Why?
|
Predictive Value of Tests | 3 | 2015 | 15076 | 0.190 |
Why?
|
Hypertension, Pulmonary | 4 | 2018 | 1537 | 0.190 |
Why?
|
Neonatal Abstinence Syndrome | 2 | 1994 | 109 | 0.190 |
Why?
|
Pulmonary Circulation | 4 | 2003 | 739 | 0.190 |
Why?
|
Cephalexin | 1 | 2020 | 37 | 0.190 |
Why?
|
Hydrogen-Ion Concentration | 3 | 2015 | 2557 | 0.180 |
Why?
|
Sus scrofa | 2 | 2013 | 437 | 0.180 |
Why?
|
Pharmaceutical Preparations | 2 | 2007 | 1071 | 0.180 |
Why?
|
Hemoptysis | 1 | 2021 | 155 | 0.180 |
Why?
|
Vital Signs | 1 | 2020 | 142 | 0.170 |
Why?
|
Male | 43 | 2021 | 350118 | 0.170 |
Why?
|
Lung Diseases | 3 | 2001 | 1886 | 0.170 |
Why?
|
Retrospective Studies | 19 | 2021 | 77449 | 0.160 |
Why?
|
Total Lung Capacity | 1 | 1998 | 143 | 0.160 |
Why?
|
Fentanyl | 2 | 1991 | 410 | 0.160 |
Why?
|
Critical Illness | 4 | 2021 | 2670 | 0.150 |
Why?
|
Administration, Inhalation | 3 | 2016 | 1105 | 0.150 |
Why?
|
Models, Biological | 4 | 2009 | 9583 | 0.150 |
Why?
|
Electrocardiography | 1 | 2011 | 6442 | 0.150 |
Why?
|
Female | 38 | 2021 | 380194 | 0.140 |
Why?
|
Pediatrics | 2 | 2007 | 3475 | 0.140 |
Why?
|
Fluoroscopy | 1 | 2001 | 924 | 0.140 |
Why?
|
Hyaline Membrane Disease | 2 | 1996 | 19 | 0.140 |
Why?
|
Arthritis, Infectious | 1 | 2020 | 367 | 0.140 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2010 | 8949 | 0.140 |
Why?
|
Osteomyelitis | 1 | 2020 | 402 | 0.140 |
Why?
|
Pneumonia | 1 | 2008 | 2133 | 0.130 |
Why?
|
Acute Disease | 6 | 2007 | 7149 | 0.130 |
Why?
|
Vasodilator Agents | 1 | 1999 | 977 | 0.130 |
Why?
|
Probability | 5 | 2019 | 2505 | 0.130 |
Why?
|
Polymorphism, Genetic | 1 | 2005 | 4328 | 0.120 |
Why?
|
Immunocompromised Host | 2 | 2015 | 847 | 0.120 |
Why?
|
Drug Monitoring | 1 | 2001 | 956 | 0.120 |
Why?
|
Continuous Positive Airway Pressure | 1 | 2019 | 546 | 0.120 |
Why?
|
Computer Systems | 1 | 2016 | 483 | 0.120 |
Why?
|
Intubation, Intratracheal | 4 | 2020 | 1364 | 0.120 |
Why?
|
Meconium Aspiration Syndrome | 2 | 2003 | 29 | 0.120 |
Why?
|
Aerosols | 1 | 2016 | 625 | 0.110 |
Why?
|
Functional Residual Capacity | 1 | 2012 | 68 | 0.110 |
Why?
|
Neuropsychological Tests | 1 | 2006 | 6993 | 0.110 |
Why?
|
Vascular Resistance | 3 | 2003 | 936 | 0.110 |
Why?
|
Standard of Care | 1 | 2016 | 564 | 0.110 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2016 | 1572 | 0.100 |
Why?
|
Bronchial Spasm | 1 | 2012 | 73 | 0.100 |
Why?
|
Treatment Outcome | 14 | 2017 | 63114 | 0.100 |
Why?
|
Length of Stay | 4 | 2020 | 6309 | 0.100 |
Why?
|
Human Experimentation | 1 | 1992 | 127 | 0.100 |
Why?
|
Staphylococcal Infections | 1 | 2020 | 1400 | 0.100 |
Why?
|
Cross-Over Studies | 2 | 2012 | 2029 | 0.090 |
Why?
|
Fuzzy Logic | 1 | 2010 | 56 | 0.090 |
Why?
|
Medical Audit | 1 | 2011 | 467 | 0.090 |
Why?
|
Tomography, X-Ray Computed | 1 | 2013 | 20129 | 0.090 |
Why?
|
Models, Theoretical | 2 | 2016 | 3589 | 0.090 |
Why?
|
Botulism | 1 | 2009 | 21 | 0.090 |
Why?
|
Automation | 2 | 2010 | 584 | 0.090 |
Why?
|
Tandem Mass Spectrometry | 1 | 2016 | 1157 | 0.090 |
Why?
|
Therapeutic Irrigation | 2 | 2001 | 301 | 0.090 |
Why?
|
Resuscitation | 1 | 1994 | 658 | 0.090 |
Why?
|
Technology Assessment, Biomedical | 1 | 1992 | 306 | 0.090 |
Why?
|
Biomedical Technology | 1 | 1992 | 220 | 0.090 |
Why?
|
Electrodes | 1 | 2011 | 619 | 0.090 |
Why?
|
Specialization | 1 | 1994 | 777 | 0.080 |
Why?
|
Dose-Response Relationship, Drug | 4 | 2010 | 10943 | 0.080 |
Why?
|
Adenoviruses, Human | 1 | 2010 | 257 | 0.080 |
Why?
|
Spirometry | 1 | 2011 | 864 | 0.080 |
Why?
|
Fungemia | 1 | 2008 | 53 | 0.080 |
Why?
|
Survival Rate | 5 | 2021 | 12788 | 0.080 |
Why?
|
Hirschsprung Disease | 1 | 2009 | 155 | 0.080 |
Why?
|
Biopsy, Needle | 1 | 2013 | 1641 | 0.080 |
Why?
|
Feasibility Studies | 2 | 2016 | 5078 | 0.080 |
Why?
|
Catheters | 1 | 2011 | 425 | 0.080 |
Why?
|
Shock, Septic | 1 | 1994 | 775 | 0.070 |
Why?
|
Reference Values | 2 | 2013 | 4982 | 0.070 |
Why?
|
Equipment Failure Analysis | 1 | 2010 | 868 | 0.070 |
Why?
|
Confidence Intervals | 1 | 2013 | 2971 | 0.070 |
Why?
|
Anesthetics, Inhalation | 1 | 2012 | 570 | 0.070 |
Why?
|
Infant, Premature | 3 | 2004 | 2044 | 0.070 |
Why?
|
Suction | 1 | 2007 | 267 | 0.070 |
Why?
|
Electronic Health Records | 2 | 2020 | 4468 | 0.070 |
Why?
|
Patient Care | 1 | 1992 | 640 | 0.070 |
Why?
|
Nursing Assessment | 1 | 2006 | 107 | 0.070 |
Why?
|
Analysis of Variance | 2 | 2013 | 6365 | 0.070 |
Why?
|
Intubation | 1 | 2006 | 141 | 0.070 |
Why?
|
Software | 2 | 2017 | 4443 | 0.070 |
Why?
|
Severity of Illness Index | 3 | 2021 | 15540 | 0.070 |
Why?
|
Fungi | 1 | 2008 | 327 | 0.060 |
Why?
|
Chest Wall Oscillation | 1 | 2004 | 12 | 0.060 |
Why?
|
Infant, Newborn, Diseases | 1 | 1990 | 582 | 0.060 |
Why?
|
Work of Breathing | 1 | 2004 | 51 | 0.060 |
Why?
|
Oxygenators, Membrane | 1 | 2004 | 56 | 0.060 |
Why?
|
Water-Electrolyte Balance | 1 | 2005 | 346 | 0.060 |
Why?
|
Internet | 1 | 2017 | 3064 | 0.060 |
Why?
|
Time Factors | 6 | 2018 | 40075 | 0.060 |
Why?
|
Inflammation Mediators | 1 | 2013 | 1889 | 0.060 |
Why?
|
Patient Discharge | 2 | 2021 | 3313 | 0.060 |
Why?
|
Anti-Bacterial Agents | 2 | 2020 | 7181 | 0.060 |
Why?
|
Nystatin | 1 | 2002 | 23 | 0.060 |
Why?
|
Research Design | 2 | 2006 | 5987 | 0.060 |
Why?
|
Candidiasis, Oral | 1 | 2002 | 60 | 0.060 |
Why?
|
Health Status | 1 | 2016 | 4034 | 0.050 |
Why?
|
Fluconazole | 1 | 2002 | 146 | 0.050 |
Why?
|
Antifungal Agents | 2 | 2008 | 730 | 0.050 |
Why?
|
Anesthetics | 1 | 2008 | 539 | 0.050 |
Why?
|
Boston | 2 | 2012 | 9313 | 0.050 |
Why?
|
Models, Animal | 1 | 2008 | 2171 | 0.050 |
Why?
|
Posture | 1 | 2006 | 958 | 0.050 |
Why?
|
Socioeconomic Factors | 1 | 2015 | 7785 | 0.050 |
Why?
|
Logistic Models | 2 | 2010 | 13408 | 0.050 |
Why?
|
Pressure | 1 | 2004 | 1203 | 0.050 |
Why?
|
Chronic Disease | 2 | 2015 | 9146 | 0.050 |
Why?
|
Bacteremia | 1 | 2008 | 962 | 0.050 |
Why?
|
Shock | 1 | 2003 | 318 | 0.050 |
Why?
|
Antifibrinolytic Agents | 1 | 2003 | 254 | 0.050 |
Why?
|
Antibodies, Neutralizing | 1 | 2010 | 1978 | 0.050 |
Why?
|
Clinical Protocols | 2 | 2005 | 1462 | 0.050 |
Why?
|
Drug Tolerance | 2 | 1993 | 376 | 0.050 |
Why?
|
Instillation, Drug | 1 | 1999 | 32 | 0.050 |
Why?
|
Reproducibility of Results | 4 | 2006 | 19905 | 0.040 |
Why?
|
Peroxidase | 1 | 2003 | 611 | 0.040 |
Why?
|
Multivariate Analysis | 3 | 2004 | 12245 | 0.040 |
Why?
|
Lung Diseases, Obstructive | 1 | 2000 | 316 | 0.040 |
Why?
|
Pilot Projects | 1 | 2012 | 8324 | 0.040 |
Why?
|
Emulsions | 1 | 1999 | 156 | 0.040 |
Why?
|
Methicillin Resistance | 1 | 2020 | 198 | 0.040 |
Why?
|
Nitrogen Dioxide | 2 | 1999 | 490 | 0.040 |
Why?
|
Immunohistochemistry | 1 | 2013 | 11366 | 0.040 |
Why?
|
Partial Pressure | 1 | 2019 | 254 | 0.040 |
Why?
|
Antibodies, Viral | 1 | 2010 | 3176 | 0.040 |
Why?
|
Heart Diseases | 1 | 2012 | 2788 | 0.040 |
Why?
|
Calibration | 1 | 2001 | 816 | 0.040 |
Why?
|
Adult | 13 | 2009 | 214055 | 0.040 |
Why?
|
Empirical Research | 1 | 2019 | 120 | 0.040 |
Why?
|
Heart Valve Prosthesis Implantation | 2 | 2000 | 1536 | 0.040 |
Why?
|
Sodium Chloride | 1 | 2001 | 625 | 0.040 |
Why?
|
Ventilation-Perfusion Ratio | 1 | 1998 | 116 | 0.040 |
Why?
|
Intensive Care Units, Neonatal | 1 | 2004 | 780 | 0.040 |
Why?
|
Epoprostenol | 1 | 2018 | 254 | 0.040 |
Why?
|
Bacteria | 1 | 2008 | 2114 | 0.040 |
Why?
|
Hemoglobins | 1 | 2003 | 1534 | 0.040 |
Why?
|
Tissue Distribution | 1 | 2001 | 2327 | 0.040 |
Why?
|
Risk Factors | 6 | 2021 | 72290 | 0.040 |
Why?
|
United States | 2 | 2019 | 69872 | 0.040 |
Why?
|
Psychometrics | 1 | 2006 | 3002 | 0.040 |
Why?
|
Infusions, Intravenous | 2 | 1991 | 2274 | 0.030 |
Why?
|
Linear Models | 2 | 2012 | 5952 | 0.030 |
Why?
|
Administration, Oral | 2 | 2020 | 3913 | 0.030 |
Why?
|
Drug Administration Schedule | 2 | 2020 | 4933 | 0.030 |
Why?
|
Models, Structural | 1 | 1996 | 361 | 0.030 |
Why?
|
Lung Transplantation | 2 | 1994 | 1153 | 0.030 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2001 | 1375 | 0.030 |
Why?
|
Patient Selection | 2 | 2000 | 4215 | 0.030 |
Why?
|
Prognosis | 3 | 2010 | 29063 | 0.030 |
Why?
|
Regional Blood Flow | 1 | 1998 | 1525 | 0.030 |
Why?
|
Longitudinal Studies | 1 | 2010 | 13989 | 0.030 |
Why?
|
Microbial Sensitivity Tests | 1 | 2020 | 1877 | 0.030 |
Why?
|
Life Support Care | 1 | 1996 | 228 | 0.030 |
Why?
|
Calorimetry | 1 | 1993 | 126 | 0.030 |
Why?
|
Rabbits | 1 | 2000 | 4894 | 0.030 |
Why?
|
Dogs | 1 | 1998 | 3912 | 0.030 |
Why?
|
Equipment Design | 1 | 2001 | 3582 | 0.030 |
Why?
|
Cardiography, Impedance | 1 | 2013 | 41 | 0.030 |
Why?
|
Vagotomy, Proximal Gastric | 1 | 1992 | 8 | 0.030 |
Why?
|
Animals, Newborn | 1 | 1998 | 2726 | 0.030 |
Why?
|
Mathematics | 1 | 1993 | 728 | 0.030 |
Why?
|
Aortic Valve | 2 | 2000 | 1922 | 0.030 |
Why?
|
Therapeutic Human Experimentation | 1 | 1992 | 43 | 0.030 |
Why?
|
Staphylococcus aureus | 1 | 2020 | 1451 | 0.030 |
Why?
|
Third-Party Consent | 1 | 1992 | 64 | 0.030 |
Why?
|
Parental Consent | 1 | 1992 | 62 | 0.030 |
Why?
|
Proxy | 1 | 2012 | 144 | 0.020 |
Why?
|
Thoracoscopy | 1 | 1992 | 178 | 0.020 |
Why?
|
Heart Valve Prosthesis | 1 | 2000 | 1488 | 0.020 |
Why?
|
Heart Rate | 1 | 2002 | 4091 | 0.020 |
Why?
|
Ethics | 1 | 1991 | 94 | 0.020 |
Why?
|
Quality of Life | 1 | 2012 | 12804 | 0.020 |
Why?
|
Genotype | 1 | 2005 | 12951 | 0.020 |
Why?
|
Euthanasia, Passive | 1 | 1991 | 66 | 0.020 |
Why?
|
Peptic Ulcer | 1 | 1992 | 223 | 0.020 |
Why?
|
Wilms Tumor | 1 | 1993 | 373 | 0.020 |
Why?
|
Megacolon | 1 | 2009 | 10 | 0.020 |
Why?
|
Midazolam | 1 | 1991 | 270 | 0.020 |
Why?
|
Research Subjects | 1 | 1992 | 239 | 0.020 |
Why?
|
Intestinal Pseudo-Obstruction | 1 | 2009 | 48 | 0.020 |
Why?
|
Mycobacterium Infections | 1 | 1970 | 119 | 0.020 |
Why?
|
Tuberculin Test | 1 | 1970 | 214 | 0.020 |
Why?
|
Evaluation Studies as Topic | 1 | 1992 | 1681 | 0.020 |
Why?
|
Antihypertensive Agents | 1 | 2018 | 2046 | 0.020 |
Why?
|
Risk Assessment | 4 | 2021 | 23338 | 0.020 |
Why?
|
Neutralization Tests | 1 | 2010 | 758 | 0.020 |
Why?
|
Mycobacterium | 1 | 1970 | 249 | 0.020 |
Why?
|
Antibody Specificity | 1 | 2010 | 1095 | 0.020 |
Why?
|
Obesity | 1 | 2010 | 12745 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2004 | 9959 | 0.020 |
Why?
|
Survival Analysis | 1 | 2000 | 10252 | 0.020 |
Why?
|
Biopsy | 1 | 1999 | 6756 | 0.020 |
Why?
|
Aortic Valve Stenosis | 1 | 2000 | 1965 | 0.020 |
Why?
|
Age Factors | 1 | 2004 | 18370 | 0.020 |
Why?
|
Regression Analysis | 1 | 1997 | 6459 | 0.020 |
Why?
|
Finite Element Analysis | 1 | 2009 | 431 | 0.020 |
Why?
|
Uncertainty | 1 | 1992 | 734 | 0.020 |
Why?
|
Blood Pressure | 1 | 2002 | 8554 | 0.020 |
Why?
|
Withholding Treatment | 1 | 1991 | 599 | 0.020 |
Why?
|
Intensive Care Units | 1 | 1999 | 3679 | 0.020 |
Why?
|
Radiography, Abdominal | 1 | 2009 | 537 | 0.020 |
Why?
|
Analgesia | 1 | 1991 | 461 | 0.020 |
Why?
|
Immunoglobulins | 1 | 2009 | 881 | 0.020 |
Why?
|
Gram-Positive Bacterial Infections | 1 | 2008 | 341 | 0.020 |
Why?
|
Models, Anatomic | 1 | 2009 | 691 | 0.020 |
Why?
|
Mycoses | 1 | 2008 | 376 | 0.020 |
Why?
|
Constipation | 1 | 2009 | 546 | 0.020 |
Why?
|
Research | 1 | 1992 | 1999 | 0.010 |
Why?
|
Prosthesis Design | 2 | 2000 | 2110 | 0.010 |
Why?
|
Risk | 2 | 1992 | 9687 | 0.010 |
Why?
|
Diagnostic Errors | 1 | 2009 | 1257 | 0.010 |
Why?
|
Motor Activity | 1 | 1991 | 2714 | 0.010 |
Why?
|
Hypersensitivity | 1 | 1970 | 1102 | 0.010 |
Why?
|
Laparoscopy | 1 | 1992 | 2151 | 0.010 |
Why?
|
Gastrointestinal Diseases | 1 | 2008 | 1170 | 0.010 |
Why?
|
Opioid-Related Disorders | 1 | 1994 | 2065 | 0.010 |
Why?
|
Terminal Care | 1 | 1991 | 1694 | 0.010 |
Why?
|
Multicenter Studies as Topic | 1 | 2003 | 1677 | 0.010 |
Why?
|
Diagnosis, Differential | 2 | 2009 | 12959 | 0.010 |
Why?
|
Tuberculosis | 1 | 1970 | 1912 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2012 | 14722 | 0.010 |
Why?
|
Bioprosthesis | 1 | 2000 | 596 | 0.010 |
Why?
|
Stress, Psychological | 1 | 1991 | 4245 | 0.010 |
Why?
|
Methemoglobin | 1 | 1994 | 26 | 0.010 |
Why?
|
Infusions, Intra-Arterial | 1 | 1994 | 234 | 0.010 |
Why?
|
Morbidity | 1 | 1998 | 1769 | 0.010 |
Why?
|
Body Mass Index | 1 | 2010 | 12720 | 0.010 |
Why?
|
Pleurisy | 1 | 1992 | 53 | 0.010 |
Why?
|
Acetylcholine | 1 | 1994 | 621 | 0.010 |
Why?
|
Cohort Studies | 1 | 1995 | 40561 | 0.010 |
Why?
|
Transplantation, Homologous | 1 | 2000 | 4776 | 0.010 |
Why?
|
Biocompatible Materials | 1 | 2000 | 1736 | 0.010 |
Why?
|
Euthanasia, Active | 1 | 1991 | 15 | 0.010 |
Why?
|
Double Effect Principle | 1 | 1991 | 14 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2012 | 25043 | 0.010 |
Why?
|
Follow-Up Studies | 2 | 2003 | 39050 | 0.010 |
Why?
|
Euthanasia | 1 | 1991 | 51 | 0.010 |
Why?
|
Jurisprudence | 1 | 1991 | 110 | 0.010 |
Why?
|
Gastric Juice | 1 | 1970 | 63 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2008 | 21746 | 0.010 |
Why?
|
Sepsis | 1 | 2003 | 2593 | 0.010 |
Why?
|
Pleural Effusion | 1 | 1992 | 338 | 0.010 |
Why?
|
Mediastinal Neoplasms | 1 | 1992 | 423 | 0.010 |
Why?
|
Intention | 1 | 1991 | 341 | 0.000 |
Why?
|
Attitude to Death | 1 | 1991 | 382 | 0.000 |
Why?
|
Clinical Trials as Topic | 1 | 2003 | 7913 | 0.000 |
Why?
|
Video Recording | 1 | 1992 | 949 | 0.000 |
Why?
|
Tissue and Organ Procurement | 1 | 1994 | 896 | 0.000 |
Why?
|
Public Policy | 1 | 1991 | 572 | 0.000 |
Why?
|
Medical History Taking | 1 | 1970 | 783 | 0.000 |
Why?
|
Young Adult | 1 | 2012 | 56430 | 0.000 |
Why?
|
Tissue Donors | 1 | 1994 | 2240 | 0.000 |
Why?
|
Hospital Mortality | 1 | 1998 | 5317 | 0.000 |
Why?
|
Antigens | 1 | 1970 | 1466 | 0.000 |
Why?
|
Radiography, Thoracic | 1 | 1970 | 1265 | 0.000 |
Why?
|
Body Weight | 1 | 1994 | 4669 | 0.000 |
Why?
|
Motivation | 1 | 1991 | 1971 | 0.000 |
Why?
|
Aged | 3 | 2000 | 163280 | 0.000 |
Why?
|
Lymph Nodes | 1 | 1970 | 3474 | 0.000 |
Why?
|
Neoplasm Staging | 1 | 1992 | 11031 | 0.000 |
Why?
|
Health Personnel | 1 | 1991 | 3218 | 0.000 |
Why?
|
Decision Making | 1 | 1991 | 3887 | 0.000 |
Why?
|
Postoperative Complications | 1 | 1998 | 15295 | 0.000 |
Why?
|
Pain | 1 | 1991 | 4986 | 0.000 |
Why?
|
Aged, 80 and over | 1 | 1998 | 57776 | 0.000 |
Why?
|
Middle Aged | 2 | 2000 | 213383 | 0.000 |
Why?
|
Physicians | 1 | 1991 | 4567 | 0.000 |
Why?
|
Lung Neoplasms | 1 | 1992 | 13102 | 0.000 |
Why?
|